AHRR and lung carcinoma: In a recent case–control study (N=552 pairs) lower methylation of both AHRR CpG3 and F2RL3 CpG2 in blood was associated with higher risk of lung cancer and the authors proposed that DNA methylation of the two studied CpG sites might be a predictor of future lung cancer (50).